Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a)

Lipoprotein(a)

(2012) Joseph B. Dubé et al.   CURRENT OPINION IN LIPIDOLOGY

So Many Plasminogen Receptors: Why?

(2012) Edward F. Plow et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease

(2012) Sotirios Tsimikas et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease

(2012) A. GODIER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Plasminogen and Its Receptors as Regulators of Cardiovascular Inflammatory Responses

(2011) Riku Das et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Lipoprotein(a) and ischemic heart disease—A causal association? A review

(2010) Pia R. Kamstrup   ATHEROSCLEROSIS

Analysis of the mechanism of lipoprotein(a) assembly

(2010) Marlys L. Koschinsky et al.   CLINICAL GENETICS

Lipoprotein(a) as a cardiovascular risk factor: current status

(2010) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

A Novel Function of Thrombin-activatable Fibrinolysis Inhibitor during Rat Liver Regeneration and in Growth-promoted Hepatocytes in Primary Culture

(2009) Nobuaki Okumura et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lipoprotein(a) Levels and Risk of Future Coronary Heart DiseaseLarge-Scale Prospective Data

(2008) Anna Bennet   ARCHIVES OF INTERNAL MEDICINE

Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation

(2008) N. T. FERIC et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS